Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ip GmbhfiledCriticalBayer Ip Gmbh
Priority to CR20120445ApriorityCriticalpatent/CR20120445A/en
Publication of CR20120445ApublicationCriticalpatent/CR20120445A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente solicitud se refiere a nuevos derivados de 5-aril-1,2,4-triazolona ligada a bisarilo, a procesos para prepararlos, a su uso solos o en combinaciones para el tratamiento y/o la prevención de enfermedades y también a su uso para la producción de medicamentos para el tratamiento y/o la prevención de enfermedades, más particularmente para el tratamiento y/o la prevención de trastornos cardiovasculares.The present application refers to new derivatives of 5-aryl-1,2,4-triazolone linked to bisaryl, to processes for preparing them, for use alone or in combinations for the treatment and / or prevention of diseases and also their use for the production of medicaments for the treatment and / or prevention of diseases, more particularly for the treatment and / or prevention of cardiovascular disorders.
CR20120445A2012-08-272012-08-27
ARILTRIAZOLONAS LINKED TO BISARILO AND ITS USE
CR20120445A
(en)